This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Sriram Sathy, Ph.D.
Chief Scientific Officer at AIRNA
Speaker

Profile

Sriram Sathy, Ph.D. is Chief Scientific Officer at AIRNA Biotechnology with over three decades of experience in genetic medicine, cancer biology, immunology, and neuroscience. He has advanced antibodies, exosomes, and antisense oligonucleotides from concept to clinic. Previously, as CSO of Codiak Biosciences, he led the development of first-in-class engineered exosome therapeutics (exoIL-12™, exoSTING™, exoASO™-STAT6) for cancer. He also held leadership roles at Jounce Therapeutics and Merck Research Laboratories. Sriram earned his Ph.D. from the Indian Institute of Science and completed postdoctoral research at the University of Pennsylvania. Based in Lexington, MA, he is also an avid long-distance cyclist and passionate advocate for cancer research.

Agenda Sessions

  • Building a Best-in-class RNA Editing Platform for the Treatment of Genetic Diseases

    17:00